nach oben

Erschienen in:

01.02.2014 | Original Article

Alendronate and risk of lower limb ischemic vascular events: a population-based cohort study

verfasst von: C.-K. Chen, H.-T. Chang, H.-P. Chou, M.-H. Lee, Y.-C. Chen, Y.-C. Huang, T.-J. Chen, H.-L. Chang, C.-C. Shih

Erschienen in: Osteoporosis International | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Summary

While alendronate inhibits atherosclerosis experimentally, its effect on lower limb ischemia risk is unknown. Our results suggest that alendronate reduces the risk of lower limb ischemic vascular events requiring surgical interventions, including amputation. Our results are relevant for patients at risk of lower limb ischemia undergoing fragility fracture treatment.

Introduction

This study aimed to determine the association between alendronate therapy and the risk of lower limb ischemic vascular events (i.e., bypass surgery, endovascular stenting, and major lower limb amputation for lower limb ischemia).

Methods

We used a nationwide population-based cohort of patients aged over 50 years diagnosed with a vertebral or hip fracture between January 1999 and June 2010. We compared the risk of lower limb ischemic vascular events between patients undergoing treatment with alendronate (n = 3,731) and an age- and sex-matched comparison group (n = 7,462) over 5 years of follow-up. Hazard ratios (HR) were estimated using Cox proportional regression analysis with adjustment for treatment status, comorbidities, and other variables.

Results

Ten patients (0.3 %) in the alendronate treatment group had a lower limb ischemic vascular event compared with 51 patients (0.7 %) in the comparison group. The incidence of lower limb ischemic vascular events was 8.4 (95 % CI, 4.0–15.5) per 10,000 person-years in the alendronate group and 21.8 (95 % CI, 16.2–28.7) per 10,000 person-years in the comparison group. The risk of a lower limb ischemic vascular event in the alendronate treatment group was lower (adjusted HR, 0.41; 95 % CI, 0.21–0.82).

Conclusion

Alendronate treatment was associated with a reduced risk of lower limb ischemic vascular events among hip or vertebral fragility fracture patients.

Kramsch DM, Chan CT (1978) The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits. Circ Res 42:562–571PubMedCrossRef

Price PA, Faus SA, Williamson MK (2001) Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler, Thromb, Vasc Biol 21:817–824CrossRef

Celiloglu M, Aydin Y, Balci P, Kolamaz T (2009) The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis. Menopause 16:689–693PubMedCrossRef

Adami S, Braga V, Guidi G, Gatti D, Gerardi D, Fracassi E (2000) Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol. J Bone Miner Res 15:599–604PubMedCrossRef

Koshiyama H, Nakamura Y, Tanaka S, Minamikawa J (2000) Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes. J Clin Endocrinol Metab 85:2793–2796PubMed

Nitta K, Akiba T, Suzuki K, Uchida K, Watanabe R, Majima K, Aoki T, Nihei H (2004) Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 44:680–688PubMed

Kang JH, Keller JJ, Lin HC (2012) A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke. Osteoporos Int 23:2551–2557PubMedCrossRef

Lu PY, Hsieh CF, Tsai YW, Huang WF (2011) Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate. Clin Ther 33:1173–1179PubMedCrossRef

Kang JH, Keller JJ, Lin HC (2013) Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study. Osteoporos Int 24:271–277PubMedCrossRef

10.

Tentolouris N, Al-Sabbagh S, Walker MG, Boulton AJ, Jude EB (2004) Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study. Diabetes Care 27:1598–1604PubMedCrossRef

11.

Department of Statistics (2009) Statistical Yearbook of Interior 2009. Ministry of the Interior. http://sowf.moi.gov.tw/stat/year/y02-01.xls. Accessed Feb 18 2013

12.

Office of Statistics (2010) The National Health Insurance Statistics 2009. Bureau of National Health Insurance. http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=296&WD_ID=296&webdata_id=3419. Accessed Feb 18 2013

13.

Wen CP, Tsai SP, Chung WS (2008) A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med 148:258–267PubMedCrossRef

14.

Goodney PP, Travis LL, Nallamothu BK, Holman K, Suckow B, Henke PK, Lucas FL, Goodman DC, Birkmeyer JD, Fisher ES (2012) Variation in the use of lower extremity vascular procedures for critical limb ischemia. Circ Cardiovasc Qual Outcome 5:94–102CrossRef

15.

O’Brien-Irr MS, Harris LM, Dosluoglu HH, Dryjski ML (2012) Procedural trends in the treatment of peripheral arterial disease by insurer status in New York State. J Am Coll Surg 215(311–321):e311CrossRef

16.

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef

17.

Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619PubMedCrossRef

18.

Chen YC, Wu JC, Liu L, Chen TJ, Huang WC, Cheng H (2011) Correlation between ventriculoperitoneal shunts and inguinal hernias in children: an 8-year follow-up. Pediatrics 128:e121–e126PubMedCrossRef

19.

Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20:1912–1920PubMedCrossRef

20.

Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR (2000) Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 15:1974–1980PubMedCrossRef

21.

Hyder JA, Allison MA, Wong N, Papa A, Lang TF, Sirlin C, Gapstur SM, Ouyang P, Carr JJ, Criqui MH (2009) Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study. Am J Epidemiol 169:186–194PubMedCrossRef

22.

Parhami F, Garfinkel A, Demer LL (2000) Role of lipids in osteoporosis. Arterioscler, Thromb, Vasc Biol 20:2346–2348CrossRef

23.

Armour KJ, Armour KE, van’t Hof RJ, Reid DM, Wei XQ, Liew FY, Ralston SH (2001) Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum 44:2790–2796PubMedCrossRef

24.

John Camm A (2010) Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis. Clin Ther 32:426–436PubMedCrossRef

25.

Abola MT, Bhatt DL, Duval S et al (2012) Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes. Atherosclerosis 221:527–535PubMedCrossRef

26.

de Leur K, van Zeeland ML, Ho GH, de Groot HG, Veen EJ, van der Laan L (2012) Treatment for critical lower limb ischemia in elderly patients. World J Surg 36:2937–2943PubMedCrossRef

27.

Jeffcoate WJ, Margolis DJ (2012) Incidence of major amputation for diabetes in Scotland sets a target for us all. Diabetes Care 35:2419–2420PubMedCrossRef

28.

Li Y, Burrows NR, Gregg EW, Albright A, Geiss LS (2012) Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988–2008. Diabetes Care 35:273–277PubMedCrossRef

29.

Ylitalo R, Monkkonen J, Urtti A, Ylitalo P (1996) Accumulation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits. J Lab Clin Med 127:200–206PubMedCrossRef

30.

Duer MJ, Friscic T, Proudfoot D, Reid DG, Schoppet M, Shanahan CM, Skepper JN, Wise ER (2008) Mineral surface in calcified plaque is like that of bone: further evidence for regulated mineralization. Arterioscler, Thromb, Vasc Biol 28:2030–2034CrossRef

31.

Aikawa E, Nahrendorf M, Figueiredo JL, Swirski FK, Shtatland T, Kohler RH, Jaffer FA, Aikawa M, Weissleder R (2007) Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 116:2841–2850PubMedCrossRef

32.

Lusis AJ (2000) Atherosclerosis. Nature 407:233–241PubMedCentralPubMedCrossRef

33.

Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Moorehead TJ, Parmley WW (1994) Effects of etidronate and lovastatin on the regression of atherosclerosis in cholesterol-fed rabbits. Cardiology 85:370–377PubMedCrossRef

34.

Delibasi T, Emral R, Erdogan MF, Kamel N (2007) Effects of alendronate sodium therapy on carotid intima media thickness in postmenopausal women with osteoporosis. Adv Ther 24:319–325PubMedCrossRef

35.

Elmariah S, Delaney JA, O’Brien KD, Budoff MJ, Vogel-Claussen J, Fuster V, Kronmal RA, Halperin JL (2010) Bisphosphonate use and prevalence of valvular and vascular calcification in women MESA (The Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 56:1752–1759PubMedCentralPubMedCrossRef

36.

Kawahara T, Nishikawa M, Furusawa T, Inazu T, Suzuki G (2011) Effect of atorvastatin and etidronate combination therapy on regression of aortic atherosclerotic plaques evaluated by magnetic resonance imaging. J Atheroscler Thromb 18:384–395PubMedCrossRef

37.

Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L (2011) Stroke in relation to use of raloxifene and other drugs against osteoporosis. Osteoporos Int 22:1037–1045PubMedCrossRef

38.

Vestergaard P (2012) Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones? Calcif Tissue Int 90:22–29PubMedCrossRef

39.

Wolfe F, Bolster MB, O’Connor CM, Michaud K, Lyles KW, Colon-Emeric CS (2012) Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis. J Bone Miner Res. doi:10.1002/jbmr.1792

Titel: Alendronate and risk of lower limb ischemic vascular events: a population-based cohort study
verfasst von: C.-K. Chen
H.-T. Chang
H.-P. Chou
M.-H. Lee
Y.-C. Chen
Y.-C. Huang
T.-J. Chen
H.-L. Chang
C.-C. Shih
Publikationsdatum: 01.02.2014
Verlag: Springer London
Erschienen in: Osteoporosis International / Ausgabe 2/2014
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-013-2478-3

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Summary

Introduction

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2014

Milk consumption throughout life and bone mineral content and density in elderly men and women

Optimizing fracture prevention: the fracture liaison service, an observational study

An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6

Frailty and osteoporosis in older women—a prospective study

Importance of fat mass and lean mass on bone health in men: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV)